Literature DB >> 9801831

beta-1,4-Galactosyltransferase-catalyzed synthesis of the branched tetrasaccharide repeating unit of Streptococcus pneumoniae type 14.

J Niggemann1, J P Kamerling, J F Vliegenthart.   

Abstract

A chemoenzymatic approach is described towards the branched tetrasaccharide repeating unit, beta-D-Galp- (1-->4)-beta-D-Glcp-(1-->6)-[beta-D-Galp-(1-->4)]-beta-D-GlcpNac, of Streptococcus pneumoniae type 14 in a form suitable for conjugation. The linear trisaccharide acceptor, beta-D-Galp-(1-->4)-beta-D-Glcp-(1-->6)-beta-D-GlcpNAc-(1-->O)CH2CH++ + = CH2, was synthesized by coupling of peracetylated lactosyl trichloroacetimidate to a suitably protected glucosamine building block and subsequent deprotection steps. The obtained derivative was found to be a good acceptor for bovine milk beta-1,4-galactosyltransferase, and the resulting branched tetrasaccharide beta-allyl glycoside was isolated and characterized by NMR spectroscopy and FAB mass spectrometry. Reaction of the anomeric allyl function with cysteamine under UV-irradiation gave the beta-aminoethylthio-extended glycoside suitable for further coupling of the tetrasaccharide to protein carriers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9801831     DOI: 10.1016/s0968-0896(98)00095-9

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Towards a synthetic pneumococcal vaccine: synthetic oligosaccharides as tools for improving the specificity of enzyme-linked immunosorbent assays.

Authors:  H Snippe; W T Jansen; J P Kamerling; D J Lefeber
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Donor substrate regeneration for efficient synthesis of globotetraose and isoglobotetraose.

Authors:  Jun Shao; Jianbo Zhang; Przemyslaw Kowal; Peng George Wang
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

Review 3.  Harnessing glycoenzyme engineering for synthesis of bioactive oligosaccharides.

Authors:  Mounir Benkoulouche; Régis Fauré; Magali Remaud-Siméon; Claire Moulis; Isabelle André
Journal:  Interface Focus       Date:  2019-02-15       Impact factor: 3.906

4.  Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197.

Authors:  Fatme Mawas; Jutta Niggemann; Christopher Jones; Michael J Corbel; Johannis P Kamerling; Johannes F G Vliegenthart
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.